A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy

Abstract Background: Despite the certain contribution of metabolic and haemodynamic factors in diabetic nephropathy (DN), many lines of evidence highlight the role of immunologic and inflammatory mechanisms. To elucidate the contribution of the immune system in the development of DN, we explored the contribution of gene variants (polymorphisms) in relevant pathophysiologic pathways. Methods: We selected six major pathways related to immune response from the Kyoto Encyclopaedia of Genes and Genomes database and thereafter we traced all available genetic association studies (GASs) involving gene variants in these pathways from PubMed and HuGE Navigator. Finally, we used meta-analytic methods for synthesizing the results of the GASs. Results: One hundred three GASs were retrieved that included 443 variants from 75 genes. Of those variants, 138 were meta-analysed and 61 produced significant results; seven variants were investigated in single GASs and showed significant association. Variants in CCL2, CCR5, IL6, IL8, EPO, IL1A, IL1B, IL100, IL1RN, GHRL, MMP9, TGFB1, VEGFA, MMP3, MMP12, IL12RB1, PRKCE, TNF and TNFRSF19 genes were associated with an increased risk of DN. Conclusions: There is evidence that variants related with immunologic response affect the course of DN. However, the present results should be interpreted with caution since the current number of available GASs is limited.

[1]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[2]  John C. Rutledge,et al.  Role of triglyceride-rich lipoproteins in diabetic nephropathy , 2010, Nature Reviews Nephrology.

[3]  R. Zatz,et al.  Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. , 2003, Kidney international.

[4]  John P. A. Ioannidis,et al.  HEGESMA: genome search meta-analysis and heterogeneity testing , 2005, Bioinform..

[5]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[6]  J. Navarro,et al.  Inflammation and diabetic nephropathy , 2006, Current diabetes reports.

[7]  H. Makino,et al.  Microinflammation in the pathogenesis of diabetic nephropathy , 2013, Journal of diabetes investigation.

[8]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[9]  John P A Ioannidis,et al.  Heterogeneity testing in meta‐analysis of genome searches , 2005, Genetic epidemiology.

[10]  G. Remuzzi,et al.  How does proteinuria cause progressive renal damage? , 2006, Journal of the American Society of Nephrology : JASN.

[11]  Y. Moriwaki,et al.  Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats , 2007, Acta Diabetologica.

[12]  K. Tuttle.  Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. , 2005, Journal of the American Society of Nephrology : JASN.

[13]  H. Makino,et al.  Role of macrophages in the pathogenesis of diabetic nephropathy. , 2001, Contributions to nephrology.

[14]  A. Krolewski,et al.  Familial factors determine the development of diabetic nephropathy in patients with IDDM , 1996, Diabetologia.

[15]  Y. Wang,et al.  Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. , 1997, Journal of the American Society of Nephrology : JASN.

[16]  Y. Aso,et al.  Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  M. Ravid,et al.  Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. , 1998, Archives of internal medicine.

[18]  P. Dandona,et al.  Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade , 2007, Journal of Human Hypertension.

[19]  H. Makino,et al.  Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli , 1999, Diabetologia.

[20]  B. Freedman,et al.  Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  John P. A. Ioannidis,et al.  Meta-analysis for ranked discovery datasets: Theoretical framework and empirical demonstration for microarrays , 2008, Comput. Biol. Chem..

[22]  B. Kasiske,et al.  US Renal Data System 2013 Annual Data Report. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  P. Xie,et al.  Diabetic Nephropathy: Mechanisms of Renal Disease Progression , 2008, Experimental biology and medicine.

[24]  D. Thomas,et al.  Are We Ready for Genome-wide Association Studies? , 2006, Cancer Epidemiology Biomarkers & Prevention.

[25]  B. Brenner,et al.  Why is proteinuria an ominous biomarker of progressive kidney disease? , 2004, Kidney international. Supplement.

[26]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[27]  F. Jamali,et al.  Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions , 2005, Pharmacotherapy.

[28]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Carmen Gomez-Guerrero,et al.  Therapeutic approaches to diabetic nephropathy—beyond the RAS , 2014, Nature Reviews Nephrology.

[30]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[31]  G. Remuzzi,et al.  Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. , 1998, Kidney international.

[32]  G. Remuzzi,et al.  Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  P. Savage,et al.  Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. , 1989, The New England journal of medicine.

[34]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[35]  Mitsuo Kato,et al.  MicroRNAs and their role in progressive kidney diseases. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[36]  E. Zintzaras,et al.  Genomic Convergence of Genome‐wide Investigations for Complex Traits , 2009, Annals of human genetics.

[37]  E. Zintzaras.  Statistical Applications in Genetics and Molecular Biology The Generalized Odds Ratio as a Measure of Genetic Risk Effect in the Analysis and Meta-Analysis of Association Studies , 2011 .

[38]  N. Nazir,et al.  Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways , 2014, BMC Medical Genetics.

[39]  E. Zintzaras.  The power of generalized odds ratio in assessing association in genetic studies with known mode of inheritance , 2012 .

[40]  J. Lau,et al.  Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. , 2008, Journal of clinical epidemiology.

[41]  Michael Mauer,et al.  Histopathology of diabetic nephropathy. , 2007, Seminars in nephrology.

[42]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[43]  K. Chan,et al.  Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. , 2003, The Journal of clinical investigation.